Insider · CIK 0001410397

Grant Stuart

Reports to the SEC for 3 companies · BIRMINGHAM, AL

sec.gov

Transactions

Companies

Filings

CIK

0001410397

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-08-29	Patheon N.V.J Other	EVP and CFO	JOther	−196K sh	—	—	0
2017-08-29	Patheon N.V.U Disposition from Tender	EVP and CFO	UDisposition from Tender	−567K sh	$35.00	−$19.8M	0
2016-07-20	Patheon N.V.A Award	EVP and CFO	AAward	+196K sh	—	—	196,485
2014-03-11	PATHEON INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−393K sh	$7.65	−$3.01M	0
2014-03-11	PATHEON INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−125K sh	$7.47	−$934K	0
2012-06-18	PATHEON INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	550,000
2012-03-14	PATHEON INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+425K sh	—	—	425,000
2011-03-16	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−31.4K sh	—	—	55,751
2011-03-16	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−6,000 sh	$3.40	−$20.4K	57,102
2011-03-16	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−16.6K sh	—	—	87,136
2011-03-16	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−17K sh	—	—	38,751
2011-03-16	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+16.6K sh	$1.20	+$19.9K	31,332
2011-03-16	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−16.6K sh	$3.39	−$56.3K	14,717
2011-03-16	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+31.4K sh	$1.20	+$37.7K	46,102
2011-03-16	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+17K sh	$1.20	+$20.4K	63,102
2010-08-04	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+2,500 sh	$1.20	+$3,000	14,217
2010-08-04	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−2,500 sh	$6.20	−$15.5K	11,717
2010-08-04	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−2,500 sh	—	—	103,751
2010-06-03	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−1,250 sh	$6.97	−$8,712.5	11,717
2010-06-03	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+1,250 sh	$1.20	+$1,500	12,967
2010-06-03	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−1,250 sh	—	—	106,251
2010-05-03	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+1,250 sh	$1.20	+$1,500	12,967
2010-05-03	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−1,250 sh	—	—	107,501
2010-05-03	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−1,250 sh	$7.68	−$9,600	11,717
2010-04-29	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−37K sh	$8.31	−$307K	9,000
2010-04-29	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+37K sh	$3.26	+$121K	45,990
2010-04-29	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−37K sh	—	—	35,938
2010-04-28	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−1,563 sh	$8.26	−$12.9K	9,000
2010-04-28	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−1,563 sh	—	—	72,928
2010-04-28	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+1,563 sh	$3.26	+$5,095.38	10,563
2010-04-12	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−509 sh	$8.26	−$4,204.34	11,717
2010-04-12	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+509 sh	$3.26	+$1,659.34	12,226
2010-04-12	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−509 sh	—	—	74,491
2010-04-05	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−1,236 sh	$6.96	−$8,602.56	11,730
2010-04-05	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+1,249 sh	$1.20	+$1,498.8	12,966
2010-04-05	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−13 sh	$6.97	−$90.61	11,717
2010-04-05	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−1,249 sh	—	—	108,751
2010-03-03	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	SR VP & CFO	MExercise/Conversion	+15K sh	$1.20	+$18K	24,000
2010-03-03	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−15K sh	$6.96	−$104K	9,000
2010-03-03	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	SR VP & CFO	MExercise/Conversion	−15K sh	—	—	110,000
2010-03-01	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	SR VP & CFO	AAward	+45K sh	—	—	45,000
2010-01-22	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	SR VP & CFO	SSale	−17K sh	$7.02	−$120K	9,000
2009-12-31	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	SR VP & CFO	FTax Payment	−7,812 sh	$6.46	−$50.5K	26,027
2009-03-02	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	SR VP & CFO	AAward	+125K sh	$1.20	+$150K	125,000
2009-01-30	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	SR VP & CFO	PPurchase	+3,000 sh	$1.61	+$4,845	6,000
2007-08-27	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (right to buy)A Award	SR VP & CFO	AAward	+200K sh	$11.39	+$2.28M	200,000

Recent filings

Accepted (ET)
Aug 314
Grant Stuart0001209191-17-050939
SEC(opens sec.gov)
Jul 224
Patheon N.V.0001209191-16-133756
SEC(opens sec.gov)
Mar 124
PATHEON INC0001181431-14-012473
SEC(opens sec.gov)
Jun 204
Grant Stuart0001181431-12-037369
SEC(opens sec.gov)
Mar 154
Grant Stuart0001181431-12-017575
SEC(opens sec.gov)
Mar 184
Grant Stuart0001127602-11-010722
SEC(opens sec.gov)
Aug 64
Grant Stuart0001127602-10-020812
SEC(opens sec.gov)
Jun 44
Grant Stuart0001127602-10-016469
SEC(opens sec.gov)

Companies

Address

2190 PARKWAY LAKE DRIVE

BIRMINGHAM, AL, 35244-